FDA continues stretching its criminal enforcement capacity beyond US borders, moving into Southeast Asia, but the agency's Office of International Programs is shrinking its world footprint at the same time.
The Office of Criminal Investigations recently posted an agent in Singapore, the office's second outside the US
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?